Stay updated with breaking news from Kures Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DelveInsight's, Acute Pain Pipeline Insight 2023 report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Acute Pain pipeline landscape. It covers the Acute Pain...
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101
- This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD